BLRX - BioLine Rx Ltd

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development19,51011,17711,489
Selling General and Administrative5,7305,3364,707
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-25,240-16,513-16,196
Income from Continuing Operations
Total Other Income/Expenses Net9096941,902
Earnings Before Interest and Taxes-24,331-15,819-14,294
Interest Expense2122106
Income Before Tax-24,352-15,841-14,400
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-24,352-15,841-14,400
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-24,352-15,841-14,400
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-24,352-15,841-14,400